Lead Product(s) : Metaiodobenzylguanidine
Therapeutic Area : Oncology
Study Phase : Phase I
Sponsor : National Cancer Institute | Lantheus
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Metaiodobenzylguanidine is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Neuroendocrine Tumors.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 21, 2012
Lead Product(s) : Metaiodobenzylguanidine
Therapeutic Area : Oncology
Highest Development Status : Phase I
Sponsor : National Cancer Institute | Lantheus
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
